| Deep Brain Stimulation for Major Depressive Disorder (NCT00617162) | Abbott Medical Devices | 2008-03-01 |
| Advanced MRI in Major Depression (NCT00613912) | University of Aarhus | 2008-03-01 |
| Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients (NCT00655226) | Icahn School of Medicine at Mount Sinai | 2008-03-01 |
| Decentering and Relapse/Recurrence in MBCT for Depression in Adults (NCT05111665) | University of British Columbia | 2008-02-14 |
| An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (NCT00629551) | Sanofi | 2008-02-01 |
| A Safety, Efficacy and Tolerability Study of SEP-225289 (NCT00584974) | Sumitomo Pharma America, Inc. | 2007-12-01 |
| Patient Tolerability Study of GSK163090 (NCT00559299) | GlaxoSmithKline | 2007-11-01 |
| SA4503 8-Week Study in Major Depressive Disorder (MDD) (NCT00551109) | M's Science Corporation | 2007-11-01 |
| Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder (NCT01145313) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2007-10-01 |
| A Study of GW856553X For the Treatment of Depression (NCT00569062) | GlaxoSmithKline | 2007-09-12 |
| Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD (NCT00445679) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-07-01 |
| Auricular Acupuncture vs. Progressive Muscle Relaxation in Patients With Anxiety Disorders or Major Depressive Disorder. (NCT02340351) | Universitätsklinikum Hamburg-Eppendorf | 2007-07-01 |
| Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression (NCT02229825) | Boehringer Ingelheim | 2007-02-09 |
| Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR) (NCT00440427) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-02-01 |
| Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway (NCT00456898) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| A Local Register Study For Major Depression Of Paroxetine Controlled Release (NCT00368303) | GlaxoSmithKline | 2006-12-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women (NCT00406640) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Study for Evaluating Different Methods of Measuring Depression Treatment Response (NCT00406952) | Pfizer | 2006-11-01 |
| The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder (NCT00451490) | National Taiwan University Hospital | 2006-10-01 |
| Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects (NCT00366652) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder (NCT00384033) | Pfizer | 2006-09-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women (NCT00369343) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels (NCT00370058) | University of Erlangen-Nürnberg Medical School | 2006-08-01 |
| Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program (NCT00401726) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-06-01 |
| Open-label Ziprasidone Study for Psychosis Treatment in Adolescents (NCT00421954) | New York State Psychiatric Institute | 2006-05-01 |
| AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment (NCT00304746) | Mclean Hospital | 2006-04-01 |
| Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression (NCT03207438) | University of Saskatchewan | 2006-04-01 |
| Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy (NCT00150839) | University of Erlangen-Nürnberg Medical School | 2006-03-01 |
| Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder (NCT00300378) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response (NCT00285376) | Genaissance Pharmaceuticals | 2006-02-01 |
| Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression (NCT00285727) | Stanford University | 2006-01-01 |
| A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) (NCT00275197) | Pfizer | 2005-12-01 |
| Clinical and Biological Characteristics of Psychotic Depression (NCT00576095) | Stanford University | 2005-08-01 |
| Dopamine Receptor Imaging in Mood Disorders (NCT00116077) | National Institute of Mental Health (NIMH) | 2005-06-21 |
| Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD) (NCT00413023) | GlaxoSmithKline | 2005-06-01 |
| A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression (NCT00208156) | Corcept Therapeutics | 2005-05-01 |
| A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain (NCT00191919) | Eli Lilly and Company | 2005-05-01 |
| Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain (NCT02232555) | Boehringer Ingelheim | 2005-05-01 |
| Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder (NCT00143091) | Pfizer | 2005-04-01 |
| Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder (NCT00105989) | Eli Lilly and Company | 2005-03-01 |
| A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression (NCT00220480) | Sheba Medical Center | 2005-02-01 |
| Mindfulness Based Cognitive Therapy for Recurrent Depression (NCT01038765) | Radboud University Medical Center | 2005-01-01 |
| Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders (NCT00097175) | National Institute of Mental Health (NIMH) | 2004-11-10 |
| Study Of GW679769 In Major Depressive Disorder (NCT00102492) | GlaxoSmithKline | 2004-10-01 |
| Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence (NCT00149643) | University of Pittsburgh | 2004-09-01 |
| Sexual Functioning Study With Antidepressants (NCT00316160) | GlaxoSmithKline | 2004-09-01 |
| Major Depressive Disorder In The Elderly (NCT00093288) | GlaxoSmithKline | 2004-06-01 |
| A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression. (NCT00636246) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-06-01 |
| Duloxetine in the Treatment of Melancholic Depression (NCT00191685) | Eli Lilly and Company | 2004-05-01 |
| The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD (NCT00163059) | Pfizer | 2004-05-01 |
| Mothers With a History of Depression and Their 10-14 Year Old Daughters (NCT01129752) | Stanford University | 2004-02-01 |
| A Finnish Community Randomized Psychotherapy Effectiveness Study for Major Depression (NCT02314767) | Helsinki University Central Hospital | 2004-02-01 |
| Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression (NCT00186498) | Stanford University | 2004-02-01 |
| A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder (NCT00368030) | Sumitomo Pharma America, Inc. | 2004-01-01 |
| Study of Medication and Placebo Response in Major Depression (NCT00229476) | University of California, Los Angeles | 2003-12-01 |
| Genetics of Symptomatology and Treatment Response in Psychotic Major Depression (NCT00691535) | Stanford University | 2003-10-01 |
| An Expert System to Reduce Depression in Primary Care (NCT00497874) | Pro-Change Behavior Systems | 2003-07-01 |
| Depression Study In Elderly Patients (NCT00067444) | GlaxoSmithKline | 2003-06-01 |
| An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder (NCT00057213) | GlaxoSmithKline | 2003-03-01 |
| An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder (NCT00057226) | GlaxoSmithKline | 2003-03-01 |
| A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder (NCT00048204) | GlaxoSmithKline | 2002-11-04 |
| A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression (NCT00044681) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-10-01 |
| A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression (NCT00644982) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-10-01 |
| Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response? (NCT00186264) | Stanford University | 2002-08-01 |
| Estrogen and Perimenopausal Depression (NCT00229450) | University of California, Los Angeles | 2002-04-01 |
| Study of Genetic Differences in People With Depression (NCT00229463) | University of California, Los Angeles | 2002-01-01 |
| Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder (NCT00179062) | Vanderbilt University | 2000-02-01 |
| Treatment of Schizoaffective Disorder Using Mifepristone (NCT00725270) | Stanford University | 1998-04-01 |